Healthcare policy has always involved a degree of uncertainty. I have been in healthcare for over 40 years, and early in my career we would all get a copy of the latest final rules, usually around 50 pages, read them, and adjust for changes.
I was around for the implementations of the Tax Equity and Fiscal Responsibility Act (TEFRA) and the Prospective Payment System (PPS). Years of planning and organized implementation were involved. There was an understanding that systems needed to have some kind of consistency.
But the current environment – marked by political gridlock, legislative brinkmanship, and sweeping proposals like the so-called One Big Beautiful Bill Act (OBBBA) – has pushed the uncertainty to a level that makes forward-looking strategy increasingly difficult, if not impossible.
At the center of the disruption is the broader dysfunction in Washington. The narrow margins in Congress, combined with deep ideological divides, have created a cycle of short-term fixes, rather than durable policy. Continuing resolutions have replaced budgets.
The OBBBA, in its various forms, exemplifies the problem. Whether focused on fiscal restructuring, entitlement reform, or broader spending constraints, the bill signals potential shifts in Medicaid funding, Medicare payment structures, and supplemental programs like Disproportionate Share Hospital (DSH) payments and State Directed Payments (SDPs). But the signal is inconsistent. Provisions evolve, negotiations stall, and political messaging often diverges from policy reality.
Take Medicaid as a case study. States are being forced to model multiple scenarios simultaneously: block grant-like funding caps, reductions in federal matching rates, or new limits on provider taxes and intergovernmental transfers. Each of these possibilities has materially different implications for hospital reimbursement and access to care. Yet none can be reliably forecasted, because the legislative path remains unclear.
The same uncertainty extends to Medicare. Discussions regarding site-neutral payments, changes to graduate medical education funding, and adjustments to bad debt reimbursement have all surfaced in recent policy debates. Overlay that with evolving guidance from the Centers for Medicare & Medicaid Services (CMS), —particularly pertaining to SDPs and their alignment with Medicare rates, and the complexity compounds.
Complicating matters further is the legal landscape. After the fall of “Chevron Deference,” courts are increasingly active in shaping healthcare policy, particularly in areas like the 340B program and Medicaid waivers.
Health systems that would otherwise lean into innovation, whether through value-based care models or population health initiatives, are instead holding back, waiting for signals that may never fully arrive.
Ironically, the need for transformation has never been greater. Demographic pressures, workforce shortages, and rising costs demand proactive solutions. Yet the policy environment is discouraging exactly the kind of long-term thinking required to address those challenges.
Healthcare leaders are adapting by shifting from single-point forecasts to scenario-based planning. Instead of asking “what will happen,” they are asking “what could happen,” and preparing for a range of outcomes. While this approach offers some resilience, it comes at a cost: increased complexity, higher administrative burden, and a constant sense of operating in contingency mode.
Until there is greater alignment between political intent and policy execution, this environment is unlikely to stabilize. For now, the defining feature of healthcare policy is not direction; it is volatility. And in that volatility, the ability to project the future has become one of the industry’s most elusive goals.
